Crossmark

Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients

Crossref DOI link: https://doi.org/10.1007/s00228-018-2464-y

Published Online: 2018-05-02

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nagano, Daisuke

Araki, Takuya

Yanagisawa, Kunio

Ogawa, Yoshiyuki

Gohda, Fumito

Uchiumi, Hideki

Handa, Hiroshi

Nakamura, Tomonori

Yamamoto, Koujirou
License Information

Text and Data Mining valid from 2018-05-02
More Information

Article History

Received: 14 February 2018

Accepted: 19 April 2018

First Online: 2 May 2018

Compliance with ethical standards

: This study was approved by the Institutional Review Board for Clinical Trials at Gunma University Hospital and the Ethics Committee for Human Genome Analysis at Gunma University; all patients gave written informed consent prior to participating in the study.

: The authors declare that they have no conflicts of interest.